| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JVIROMET.2015.09.011 |
| P8608 | Fatcat ID | release_aw4lyrxhbvhvtm2vz3l4coofqe |
| P932 | PMC publication ID | 4633331 |
| P698 | PubMed publication ID | 26424619 |
| P50 | author | Carlos Enrique Catalano | Q39061718 |
| P2093 | author name string | William M Atkins | |
| Shiu-Lok Hu | |||
| Eri Nakatani-Webster | |||
| P2860 | cites work | Prospects of HIV Env modification as an approach to HIV vaccine design | Q37017780 |
| Toward an AIDS vaccine | Q37158259 | ||
| A functional interaction between gp41 and gp120 is observed for monomeric but not oligomeric, uncleaved HIV-1 Env gp140. | Q37252789 | ||
| Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation | Q37318042 | ||
| Toward an antibody-based HIV-1 vaccine | Q37613695 | ||
| Challenges for structure-based HIV vaccine design | Q37667763 | ||
| Broadly neutralizing antibodies against HIV-1: templates for a vaccine | Q38065391 | ||
| Assembly of the major light-harvesting complex II in lipid nanodiscs | Q39169934 | ||
| Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies | Q39698363 | ||
| The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles | Q40414065 | ||
| A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. | Q40757568 | ||
| Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1. | Q40793288 | ||
| Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus | Q41876028 | ||
| Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. | Q44455932 | ||
| Purified, proteolytically mature HIV type 1 SOSIP gp140 envelope trimers | Q45002947 | ||
| Expression of AIDS virus envelope gene in recombinant vaccinia viruses | Q45837045 | ||
| Detergents as intrinsic P-glycoprotein substrates and inhibitors. | Q45920517 | ||
| The phage lambda terminase enzyme: 2. Refolding of the gpNu1 subunit from the detergent-denatured and guanidinium hydrochloride-denatured state yields different oligomerization states and altered protein stabilities | Q47917279 | ||
| Self-association properties of the bacteriophage lambda terminase holoenzyme: implications for the DNA packaging motor. | Q54490048 | ||
| Properties of HIV Membrane Reconstituted from Its Recombinant gp160 Envelope Glycoprotein | Q60221289 | ||
| Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies | Q24561905 | ||
| HIV entry: a game of hide-and-fuse? | Q26824979 | ||
| A Blueprint for HIV Vaccine Discovery | Q26829865 | ||
| HIV: cell binding and entry | Q27008983 | ||
| Molecular architecture of native HIV-1 gp120 trimers | Q27651385 | ||
| Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer | Q27680496 | ||
| Maturation of HIV envelope glycoprotein precursors by cellular endoproteases | Q28143090 | ||
| Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1 | Q28302730 | ||
| GP120: target for neutralizing HIV-1 antibodies | Q28303124 | ||
| Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies | Q28602877 | ||
| Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 | ||
| Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody | Q29618366 | ||
| Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 | Q29619511 | ||
| The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. | Q30367176 | ||
| Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen | Q33639684 | ||
| Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines | Q33644522 | ||
| In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1 | Q33725718 | ||
| Formaldehyde-treated, heat-inactivated virions with increased human immunodeficiency virus type 1 env can be used to induce high-titer neutralizing antibody responses | Q33911809 | ||
| Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site. | Q34133551 | ||
| Broadly neutralizing antiviral antibodies | Q34323311 | ||
| Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface | Q34343380 | ||
| Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. | Q34434854 | ||
| Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. | Q34607664 | ||
| Detergent-free isolation, characterization, and functional reconstitution of a tetrameric K+ channel: the power of native nanodiscs | Q34832480 | ||
| Membrane protein assembly into Nanodiscs | Q35008328 | ||
| Chapter 11 - Reconstitution of membrane proteins in phospholipid bilayer nanodiscs | Q35012211 | ||
| Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation | Q35844026 | ||
| A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. | Q36149102 | ||
| Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses. | Q36315745 | ||
| Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9. | Q36692987 | ||
| Rational modifications of HIV-1 envelope glycoproteins for immunogen design | Q36725263 | ||
| P304 | page(s) | 15-24 | |
| P577 | publication date | 2015-09-28 | |
| P1433 | published in | Journal of Virological Methods | Q15749961 |
| P1476 | title | Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes | |
| P478 | volume | 226 |
| Q36267348 | Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs |
| Q52574242 | Covalently circularized nanodiscs; challenges and applications. |
| Q36303368 | Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction |
| Q39126044 | Nanodiscs in Membrane Biochemistry and Biophysics. |
Search more.